[vc_row][vc_column][vc_column_text] Reprinted with permission from the Foundation Fighting Blindness Blog Ophthotech, a biopharmaceutical company developing therapies for eye diseases, has enrolled the first patient in its Phase 2b clinical trial of Zimura® for people with Stargardt disease caused by mutations in the gene ABCA4. The 120-participant study will be taking place at more than 30 sites. Data and… Continue reading Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease
Month: April 2018
Two Blind Brothers Support Research to End Blindness
[vc_row][vc_column][vc_column_text]Bradford and Bryan Manning were diagnosed with Stargardt’s disease in childhood. The disorder caused gradual loss of their central vision, and it also gave them a mission: To raise awareness and help others with eye diseases. They decided to develop a clothing company and donate the earnings to support research to end blindness. Now called… Continue reading Two Blind Brothers Support Research to End Blindness